Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Companies
Patients
Investigators
Trials & Research
Regulatory
Therapeutics
News
Features
Commentary
People
Events
White Papers
Home - Commentary
HOME - COMMENTARY
Portfolio strategies for maximum effect
23 November 2009
If your company is fortunate enough to have multiple projects in your development pipeline, and assuming that you do not have an unlimited resource pool, then you will be faced with some critical choices as to which projects to support and which projects not to support. Support of a project ...
ICH-GCP: older but perhaps not wiser
29 October 2009
The ICH Harmonised Tripartite Guideline for Good Clinical Practice E6(R1), to give it its full name, was adopted in Europe in 1996 (and in the US and Japan the following year). The aim of ICH-GCP is to provide a unified standard for the EU, the US and Japan to facilitate the mutual acceptance of ...
Breathing new life into the COPD market
14 October 2009
Chronic obstructive pulmonary disease (COPD) is an umbrella term that refers to chronic lung diseases that share the common feature of restricted airflow. According to the most recent estimates from the WHO, there are currently 210 million COPD patients worldwide, of whom 80 million have moderate ...
Prevention is better than cure
14 October 2009
Safety concerns are never far from view where pharmaceutical R&D is concerned. Early pre-clinical testing helps to determine whether a new substance is likely to cause serious adverse events in humans, and whether it should be progressed to clinical trials. While this has been the case for many ...
Excellence in site identification begins at home
09 October 2009
We are all aware of a sponsor’s requirement to select investigators who are, as it states in the US Code of Federal Regulations, "qualified by training and experience as appropriate experts to investigate the drug" 1 in accordance with good clinical practices. However, the current competitive ...
Acne market fails to excite
09 October 2009
Acne, the scourge of teenagers, is a chronic condition associated with blockage of the pilosebaceous ducts typically on the face, chest and back. The blockage is manifested as a comedo or ‘blackhead’ – the pigmentation is caused by melanin arising from the hair. In cases with more severe blockage ...
>> More Home - Commentary...
MOST MENTIONED
COMPANY/ORGANISATION
GLAXOSMITHKLINE
ALKERMES
ALLERGAN
ALTER
CONDITION
DEPRESSION
ACNE
ARRHYTHMIA
ASTHMA
GEOGRAPHY
JAPAN
GERMANY
DRUG
ACLIDINIUM BROMIDE
ADAPALENE
AN-0128
ASCJ-9
About Us
Getting Started
Subscribe
FREE Trial
Advertise
Awards
White Papers
EVENTS
Expecting data for this section.
